Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.91
-0.08 (-1.14%)
At close: Feb 13, 2026, 4:00 PM EST
7.00
+0.09 (1.30%)
After-hours: Feb 13, 2026, 5:29 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Novel Therapeutics
3.95M
Novel Therapeutics Growth
-74.60%